| The genomic landscape of Merkel cell carcinoma and clinicogenomic biomarkers of response to immune checkpoint inhibitor therapy TC Knepper, M Montesion, JS Russell, ES Sokol, GM Frampton, VA Miller, ... Clinical Cancer Research 25 (19), 5961-5971, 2019 | 140 | 2019 |
| When will clinical trials finally reflect diversity? TC Knepper, HL McLeod Nature 557 (7704), 157-159, 2018 | 123 | 2018 |
| Identification of clonal hematopoiesis mutations in solid tumor patients undergoing unpaired next-generation sequencing assays CC Coombs, NK Gillis, X Tan, JS Berg, M Ball, ME Balasis, ... Clinical Cancer Research 24 (23), 5918-5924, 2018 | 96 | 2018 |
| Key lessons learned from Moffitt’s molecular tumor board: the clinical genomics action committee experience TC Knepper, GC Bell, JK Hicks, E Padron, JK Teer, TT Vo, NK Gillis, ... The oncologist 22 (2), 144-151, 2017 | 87 | 2017 |
| Propranolol induced G0/G1/S phase arrest and apoptosis in melanoma cells via AKT/MAPK pathway C Zhou, X Chen, W Zeng, C Peng, G Huang, Z Ouyang, Y Luo, X Xu, B Xu, ... Oncotarget 7 (42), 68314, 2016 | 77 | 2016 |
| Combined nivolumab and ipilimumab with or without stereotactic body radiation therapy for advanced Merkel cell carcinoma: a randomised, open label, phase 2 trial S Kim, E Wuthrick, D Blakaj, Z Eroglu, C Verschraegen, R Thapa, M Mills, ... The Lancet 400 (10357), 1008-1019, 2022 | 54 | 2022 |
| Developing drugs for tissue‐agnostic indications: a paradigm shift in leveraging cancer biology for precision medicine ND Seligson, TC Knepper, S Ragg, CM Walko Clinical Pharmacology & Therapeutics 109 (2), 334-342, 2021 | 53 | 2021 |
| Discordance of somatic mutations between Asian and Caucasian patient populations with gastric cancer F Jia, JK Teer, TC Knepper, JK Lee, HH Zhou, YJ He, HL McLeod Molecular diagnosis & therapy 21, 179-185, 2017 | 38 | 2017 |
| Large granular lymphocytic leukemia–A retrospective study of 319 cases N Dong, F Castillo Tokumori, L Isenalumhe, Y Zhang, A Tandon, ... American Journal of Hematology 96 (7), 772-780, 2021 | 29 | 2021 |
| Identification of Targetable Gene Fusions and Structural Rearrangements to Foster Precision Medicine in KRAS Wild-Type Pancreatic Cancer MJ Fusco, D Saeed-Vafa, EM Carballido, TA Boyle, M Malafa, KL Blue, ... JCO Precision Oncology 5, 65-74, 2021 | 28 | 2021 |
| DPYD Testing: Time to Put Patient Safety First SD Baker, SE Bates, GA Brooks, WL Dahut, RB Diasio, WS El-Deiry, ... Journal of Clinical Oncology 41 (15), 2701-2705, 2023 | 26 | 2023 |
| Immunoclassification characterized by CD8 and PD-L1 expression is associated with the clinical outcome of gastric cancer patients W Wang, K Wang, Z Chen, L Chen, W Guo, P Liao, D Rotroff, TC Knepper, ... Oncotarget 9 (15), 12164, 2018 | 24 | 2018 |
| EBV infection and MSI status significantly influence the clinical outcomes of gastric cancer patients H Shen, M Zhong, W Wang, P Liao, X Yin, D Rotroff, TC Knepper, ... Clinica Chimica Acta 471, 216-221, 2017 | 23 | 2017 |
| Demographic composition of select oncologic new molecular entities approved by the FDA between 2008 and 2017 A Ramamoorthy, TC Knepper, C Merenda, M Mendoza, HL McLeod, ... Clinical Pharmacology & Therapeutics 104 (5), 940-948, 2018 | 19 | 2018 |
| Copy number alterations as novel biomarkers and therapeutic targets in colorectal cancer ES Tan, TC Knepper, X Wang, JB Permuth, L Wang, JB Fleming, H Xie Cancers 14 (9), 2223, 2022 | 11 | 2022 |
| Transformation of chronic lymphocytic leukemia into B-cell acute lymphoblastic leukemia S Yun, L Zhang, MR Patel, TC Knepper, JC Chavez, J Pinilla-Ibarz Blood, The Journal of the American Society of Hematology 131 (11), 1258-1261, 2018 | 11 | 2018 |
| Clinical response to pazopanib in a patient with KDR-mutated metastatic basal cell carcinoma TC Knepper, ML Freeman, GT Gibney, HL McLeod, JS Russell Jama Dermatology 153 (6), 607-609, 2017 | 11 | 2017 |
| Molecular annotation of extramedullary acute myeloid leukemia identifies high prevalence of targetable mutations S Ball, TC Knepper, YE Deutsch, W Samra, JM Watts, TJ Bradley, O Chan, ... Cancer 128 (21), 3880-3887, 2022 | 10 | 2022 |
| Novel and Expanded Oncology Drug Approvals of 2016-PART 1: New Options in Solid Tumor Management. TC Knepper, J Saller, CM Walko Oncology (Williston Park, NY) 31 (2), 110-121, 2017 | 10 | 2017 |
| Evaluation of targeted next-generation sequencing for the management of patients diagnosed with a cancer of unknown primary MJ Fusco, TC Knepper, J Balliu, A Del Cueto, JM Laborde, SM Hooda, ... The Oncologist 27 (1), e9-e17, 2022 | 9 | 2022 |
Howard McLeodUtah Tech UniversityAdresse e-mail validée de utahtech.edu
